1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Capricor Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy Deramiocel (CAP-1002), Placebo - Muscular Dystrophies, Muscular Dystrophy, Duchenne | Phase 3 | Active not recruiting | Capricor Inc. | 106 | 2022-06-22 | 2026-08-28 |
Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Muscular Diseases (1) · Muscular Disorders, Atrophic (1) · Muscular Dystrophies (1) · Muscular Dystrophy, Duchenne (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1)
United States (1)
Craig McDonald, MD (1) · Mark Awadalla (1)